ArticleBritish journal of cancer2013

A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity.

A Gibb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.